
US Drug Pricing Deal: Trump and AstraZeneca Forge New Path for Affordable Medicines
In a big event from Washington, D.C., former President Donald Trump and global pharmaceutical firm AstraZeneca announced a landmark deal at the White House to address the high cost of prescription pharmaceuticals in the United States. The agreement, heralded as



